How can non-inferiority studies with mortality end points be ethically justified?
Dick Willems, Hanno Tan, Nikolaos Dagres, Marieke A R Bak · 2025
Read How can non-inferiority studies with mortality end points be ethically justified? by Dick Willems, Hanno Tan, Nikolaos Dagres, Marieke A R Bak (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311967.txt.
Description
Dick Willems and co-authors examine in a 2025 article when non-inferiority trials with death as the endpoint can be ethically justified. Such trials ask whether a new approach is not unacceptably worse on survival.
The analysis, informed by a literature search, uses a heart device trial the authors are part of as its running example. Justifications for choosing this design over a superiority trial are often thin, and the allowed margin is usually borrowed without argument. Patient views on the margin are rarely sought. The authors hold such trials defensible only when side benefits are proven and large, and margins win patient and ethics board assent.
Catalog record
| CREATOR | Dick Willems, Hanno Tan, Nikolaos Dagres, Marieke A R Bak |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31252 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |